Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-12

Clinical Trial Update: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates a chemotherapy regimen of vincristine, dactinomycin, and cyclophosphamide with optional radiation therapy for embryonal rhabdomy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Dactinomycin (dactinomycin)
  • Vincristine (vincristine)

Snippet

Sponsor: Japan Rhabdomyosarcoma Study Group | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN